{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:16:35Z","timestamp":1793297795756,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.annpat.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:31:57Z","timestamp":1738337517000},"page":"163-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pronostic de l\u2019ad\u00e9nocarcinome prostatique de score de Gleason 7 (3 + 4) comportant un faible taux de grade 4 - \u00c9tude r\u00e9trospective de 104\u00a0cas"],"prefix":"10.1016","volume":"45","author":[{"given":"Guillaume","family":"Abitbol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6217-5074","authenticated-orcid":false,"given":"Thomas","family":"Forzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Barthomeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-8956","authenticated-orcid":false,"given":"Quentin","family":"Doosterlinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Attencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Freyssinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-7733","authenticated-orcid":false,"given":"Jean-Ren\u00e9","family":"Tesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2025.01.002_bib0155","unstructured":"Donn\u00e9es globales d\u2019\u00e9pid\u00e9miologie des cancers - \u00c9pid\u00e9miologie des cancers [Internet]. [cit\u00e9 23\u00a0janv 2024]. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Les-chiffres-du-cancer-en-France\/Epidemiologie-des-cancers\/Donnees-globales."},{"key":"10.1016\/j.annpat.2025.01.002_bib0160","unstructured":"Le cancer de la prostate - Les cancers les plus fr\u00e9quents [Internet]. [cit\u00e9 13\u00a0mars 2023]. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Les-chiffres-du-cancer-en-France\/Epidemiologie-des-cancers\/Les-cancers-les-plus-frequents\/Cancer-de-la-prostate."},{"key":"10.1016\/j.annpat.2025.01.002_bib0165","unstructured":"Les cancers de la prostate\u00a0: points cl\u00e9s - Cancer de la prostate [Internet]. [cit\u00e9 13\u00a0mars 2023]. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Patients-et-proches\/Les-cancers\/Cancer-de-la-prostate\/Points-cles."},{"key":"10.1016\/j.annpat.2025.01.002_bib0170","unstructured":"Urofrance | Recommandations du comit\u00e9 de canc\u00e9rologie de l\u2019Association Fran\u00e7aise d\u2019Urologie - actualisation 2022\u20132024\u00a0: cancer de la prostate - diagnostic et prise en charge de la maladie localis\u00e9e - Urofrance [Internet]. [cit\u00e9 14\u00a0nov 2023]. Disponible sur\u00a0: https:\/\/www.urofrance.org\/recommandation\/recommandations-du-comite-de-cancerologie-de-lassociation-francaise-durologie-actualisation-2022-2024-cancer-de-la-prostate-diagnostic-et-prise-en-charge-de-la-maladie-localise\/."},{"key":"10.1016\/j.annpat.2025.01.002_bib0175","doi-asserted-by":"crossref","first-page":"a030411","DOI":"10.1101\/cshperspect.a030411","article-title":"Histopathology of prostate cancer","volume":"7","author":"Humphrey","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.annpat.2025.01.002_bib0180","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ajcp\/aqaa130","article-title":"Gleason score evolution and the effect on prostate cancer outcomes","volume":"155","author":"Swanson","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0185","first-page":"58","article-title":"The evolving Gleason grading system","volume":"28","author":"Chen","year":"2016","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.annpat.2025.01.002_bib0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/pin.12398","article-title":"Recent advances in prostate cancer pathology: Gleason grading and beyond","volume":"66","author":"Shah","year":"2016","journal-title":"Pathol Int"},{"key":"10.1016\/j.annpat.2025.01.002_bib0195","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005\u00a0International Society of Urological Pathology (ISUP) Consensus Conference on gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0200","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014\u00a0International Society of Urological Pathology (ISUP) Consensus Conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0205","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019\u00a0International Society of Urological Pathology (ISUP) Consensus Conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0210","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/PAS.0000000000000235","article-title":"Gleason Score 3+4=7\u00a0prostate cancer with minimal quantity of gleason pattern 4\u00a0on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen","volume":"38","author":"Huang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5489\/cuaj.2806","article-title":"Active surveillance for the management of localized prostate cancer: Guideline recommendations","volume":"9","author":"Morash","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.annpat.2025.01.002_bib0220","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/PAS.0000000000001345","article-title":"Cases having a Gleason score 3+4=7\u00a0with <5\u00a0% of Gleason pattern 4\u00a0in prostate needle biopsy show similar failure-free survival and adverse pathology prevalence to Gleason score 6\u00a0cases in a radical prostatectomy cohort","volume":"43","author":"Sato","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0225","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.annpat.2025.01.002_bib0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-5347(17)63039-8","article-title":"The histology and prognosis of prostatic cancer","volume":"97","author":"Mellinger","year":"1967","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-5347(17)59889-4","article-title":"Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging","volume":"111","author":"Gleason","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0240","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0046-8177(92)90108-F","article-title":"Histologic grading of prostate cancer: A perspective","volume":"23","author":"Gleason","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/modpathol.3800054","article-title":"Gleason grading and prognostic factors in carcinoma of the prostate","volume":"17","author":"Humphrey","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0250","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21681805.2016.1206619","article-title":"Interobserver variability in Gleason histological grading of prostate cancer","volume":"50","author":"Ozkan","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/his.12976","article-title":"Gleason grade 4\u00a0prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists","volume":"69","author":"Kweldam","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2025.01.002_bib0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00428-020-02902-9","article-title":"Inter-observer variability of cribriform architecture and percent Gleason pattern 4\u00a0in prostate cancer: relation to clinical outcome","volume":"478","author":"van der Slot","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2025.01.002_bib0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/hupa.2001.21135","article-title":"Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologist","volume":"32","author":"Allsbrook","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/hupa.2001.21134","article-title":"Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists","volume":"32","author":"Allsbrook","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0280","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4103\/jcrt.jcrt_827_21","article-title":"Primary signet ring cell carcinoma of prostate: A rare case report and review of literature","volume":"19","author":"Gupta","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.annpat.2025.01.002_bib0285","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5858\/arpa.2019-0456-RA","article-title":"False-negative histopathologic diagnosis of prostatic adenocarcinoma","volume":"144","author":"Yang","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.annpat.2025.01.002_bib0290","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/1066896920911087","article-title":"Atrophic and microcystic limited prostatic adenocarcinomas","volume":"28","author":"Arista-Nasr","year":"2020","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.01.002_bib0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.13472","article-title":"Gleason score assignment is the sole responsibility of the pathologist","volume":"73","author":"Varma","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2025.01.002_bib0150","doi-asserted-by":"crossref","first-page":"106856","DOI":"10.1016\/j.compbiomed.2023.106856","article-title":"A comparative study of the inter-observer variability on Gleason grading against Deep Learning-based approaches for prostate cancer","volume":"159","author":"Marr\u00f3n-Esquivel","year":"2023","journal-title":"Comput Biol Med"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649825000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649825000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:52:22Z","timestamp":1741884742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649825000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0242649825000021"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2025.01.002","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pronostic de l\u2019ad\u00e9nocarcinome prostatique de score de Gleason 7 (3+4) comportant un faible taux de grade 4 - \u00c9tude r\u00e9trospective de 104\u00a0cas","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}